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Vasodilator therapies with organic nitrates, such as glycerol trinitrite and isosorbide dinitrite, have been an integral part of treatment for more than 130 years to bring relief to patients suffering from coronary disease (7) . The beneficial vasodilator effects of organic nitrates mainly stem from their enzymatic metabolism to NO and subsequent activation of the vascular NO/cyclic GMP (cGMP) pathway (13) . Despite potent vasodilatory effects, the use of organic nitrites has been limited because of well-defined side effects and development of tolerance (45) .
Nitrite (NO 2
Ϫ
) is an endogenous metabolite of NO oxidation under normal physiological conditions (28) . Nitrite has long been believed to be relatively inert at the micromolar levels normally found in vivo, and, until recently, nitrite was thought to be inactive as a vasodilator on the basis of a report by Lauer et al. (30) in humans. In 1995, we first reported that nitrite can be a source of NO in ischemic tissues where it is reduced back to NO (65) . Recent works by a number of laboratories (3, 5, 48, 55, 61) have shown that nitrite can be recycled back to bioactive NO in both the circulation and tissues and has the potential to be a supplemental source of NO and provide therapeutic benefit. Despite initial controversy, potent vasodilating effects of nitrite have now been reported in mice, rats, dogs, sheep, primates, and humans (5, 6, 35, 37) .
Several mechanisms for the reduction of nitrite to NO have been identified by us and others including 1) nonenzymatic disproportionation at low pH (65), 2) enzyme-independent reduction (50, 64), 3) enzymatic conversion by xanthine oxidoreductase (XOR) (17, 31, 32) , 4) reduction by P450 (33), and 5) reduction by deoxyhemoglobin (deoxyHb) (27, 40) . Recently, hemoglobin (Hb)-mediated, hypoxia-induced vasodilation and NO production have been proposed; however, this remains highly controversial in view of the potent NO scavenging by Hb (25) . Most recently, it has been reported that physiological concentrations of nitrite can cause modest arterial dilation in both normoxia and hypoxia and that aortic vasorelaxation does not require Hb (36) . Thus further investigation is needed to characterize the process and mechanisms of NO generation from nitrite in vessels.
Therefore, we have functionally and analytically studied the process of nitrite-induced vasodilation in vascular tissue and provide definitive evidence that nitrite can be a precursor of EDRF and that soluble guanylate cyclase (sGC) or other heme-enzymes blocked by sGC inhibitors catalyze the reduction of nitrite to NO.
according to the approved guidelines, and conforms with the Guidelines for the Care and Use of Laboratory Animals published by the National Institutes of Health.
Animal Preparations and In Vivo BP Measurements
Male Sprague-Dawley rats weighing 300 -500 g were purchased from Harlan (Indianapolis, IN). Rats were anesthetized with a combination of low-dose pentobarbital sodium (30 mg/kg ip) and isoflurane inhalation. After adequate anesthesia and necessary shaving, rats were placed on a heated surgical plate to maintain body temperature at 37°C. Intubation was then performed with a rat tracheal catheter (Introcan Safety 14 G-2; B. Braun Medical, Bethlehem, PA), and rats were ventilated with room air with a rodent ventilator (model no. 683; Harvard Apparatus, Holliston, MA). The average breathing rate was 100 strokes/min, and the average tidal volume was 1.0 cm 3 . Under aseptic conditions, a small incision was made at right carotid area, the right carotid artery was dissected and freed from surrounding tissues, and a catheter was then inserted into the right carotid artery for blood pressure (BP) measurement. The left jugular vein was similarly dissected and cannulated for intravenous administration of nitrite. Both arterial and venous cannula were flushed with heparinized saline (10 U/ml) to prevent blood clotting. BP was continuously monitored via a MLT0699 BP transducer connected to the PowerLab/400 multichannel data acquisition system with PowerLab Chart software (ADInstruments, Castle Hill, Australia). The BP signal was digitally processed to yield systolic and diastolic pressures as well as heart rate. After surgery, at least 30 min was allowed for stabilization of BP. Following each nitrite administration, 5-10 min was allowed for the BP to stabilize. Nitrite was administered as a concentrated 200 mM stock dissolved in PBS, pH 7.4, without calcium and magnesium, and it was infused slowly over 1-3 min to achieve the final concentration calculated according to the body weight and circulating blood volume of each animal as outlined (41). The dose-dependent effects of in vivo nitrite were determined by measuring the decrease in BP from baseline, and this was expressed as the percentage decrease with respect to the maximal BP decrease from baseline by 2 mM nitrite.
Aortic Preparations and Functional Measurements
All in vitro experiments were performed on thoracic aortic rings except for electron paramagnetic resonance (EPR) experiments that used whole thoracic and abdominal aorta. After anesthesia with pentobarbital sodium (60 mg/kg), aorta were excised from heparinized rats, placed in ice-cold buffer, cleaned of loosely adhering fat and connective tissue, and cut into rings 10 mm in length for electrochemical analyzer experiments or 5 mm in length for functional organ bath experiments.
Functional measurements of vascular tone were performed as described previously with slight modification (4, 63) . Briefly, aortic rings were mounted horizontally in organ chambers filled with 20 ml of buffer (37°C, pH 7.4) of the following composition (all in mM): 118 NaCl, 4.7 KCl, 1.19 CaCl 2, 1.2 MgSO4, 1.1 KH2PO4, 25 NaHCO3, 11 glucose, and 4.6 HEPES. Several rings were cut from the same aorta and studied in parallel. In some rings, the endothelium was removed by placing a piece of stainless steel wire in the lumen and rubbing the aortic ring gently over a wet blotting paper. Each ring was connected to an isometric force transducer and suspended in an organ chamber bubbled with 95% O 2-5% CO2 gas. Aortic rings were gradually stretched to the optimal point of their length-tension curve as determined by contraction to phenylephrine (10 M). The aortic segments were allowed to equilibrate for 75 min, with the solution in the chambers changed every 15 min, and then their contractility was tested by application of phenylephrine (10 M) for 20 min. Following stable phenylephrine contraction, the vasorelaxant effects of cumulative addition of nitrite (0.001-2 mM) were determined by measuring the tension and expressing this as the percentage relaxation with respect to the maximal phenylephrine contraction. To assess the role of NO in the process of nitrite-induced vasodilation under normoxic conditions, ferrous human Hb A was used. To assess the involvement of NO-cGMP pathway in nitrite-induced vasodilation under normoxic conditions, the effects of 1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxaline-1-one (ODQ) (16) was investigated before and after administration of nitrite. ODQ was dissolved in 100% DMSO and added to the organ bath to give a final concentration of 10 M. In the pretreatment group, ODQ was first added at the peak of phenylephrine contraction, and, 10 min after ODQ treatment, nitrite was then added and the relaxation measured. In the posttreatment group, after nitrite-induced vasorelaxation in phenylephrine-contracted aortic rings, ODQ was then added.
Effects of various known inhibitors/agents were tested on nitriteinduced vasorelaxation in aerobic conditions. The inhibitors/agents were the following: 1) xanthine oxidase inhibitor, oxypurinol (43); 2) mitochondrial electron transport inhibitors, rotenone and myxothiazol (29); 3) cytochrome P-450 inhibitor, 17-octadecynoic acid (17-ODYA) (19) ; and 4) NOS inhibitor, N G -nitro-L-arginine methyl ester (L-NAME) (11) . Stock solutions for oxypurinol, rotenone, and 17-ODYA were made with DMSO. Myxothiazol was dissolved in methanol, and L-NAME was dissolved in deionized water. The final concentrations of DMSO and methanol were less than 0.2% in the organ baths. Inhibitors were used according to their reported selective concentration for each pathway. Each inhibitor was applied at the stable phenylephrine contraction and incubated for 10 -15 min, and then nitrite (500 M) was added. Vehicle (DMSO and methanol) effects for these inhibitors were also measured on nitrite-induced relaxation.
Electrochemical Experiments
These experiments were performed as reported previously (63) with modified organ chambers so the solution in the chambers could be rapidly stirred to efficiently dissolve air into solution with no gas bubbling. The aortic rings were opened longitudinally and fixed to a custom-made plastic block that was attached to the bottom of a water-jacketed chamber that was then filled with buffer that was continuously stirred (63) . Nitrite was added to the chamber containing the aortic preparation, and electrochemical measurement of the NO concentration derived from the administration of the nitrite was performed using an ISO-NOP Clark-type NO electrode (WPI, Sarasota, FL). Similar experiments were performed for denuded aortic preparations.
EPR Experiments
EPR measurements were performed using Bruker ER 300 or EMX spectrometers operating at X-band as described previously with slight modification (56, 59) . NO formation was measured using the Fe 2ϩ -diethyldithiocarbamate (DETC)2 complex, Fe 2ϩ -DETC, which forms a stable NO-Fe ϩ2 -DETC complex that exhibits a characteristic triplet EPR spectrum. Aorta was incubated in PBS with 0.5% BSA, nitrite (500 M), ammonium-iron (II) sulfate (1 mM), and DETC (2 mM), pH 7.4 at 37°C, and then frozen in liquid nitrogen. Measurements were performed in an EPR finger Dewar at 77 K using a TM 110 microwave cavity with 100 kHz modulation frequency, 4.0 G modulation amplitude, 20 mW microwave power. To assess the effects of carbon monoxide (CO) on nitrite-induced NO, aortic preparations in PBS were bubbled with 99.5% CO gas for 3 min, and NO production from nitrite (1 mM) was determined with Fe 2ϩ -DETC.
first dissolved in PBS buffer (pH 7.4) to a 2.0 mM concentration and then reduced with 5 mM dithionate under anaerobic conditions for 45 min. This mixture was quickly separated on a G-25 Sephadex column (Sigma, St. Louis, MO) and then dialyzed three times in PBS buffer for 9 h through Slide-A-Lyser Dialysis Cassette 3.5K (Pierce, Rockford, IL). PBS containing pure oxyMb (6 M) was placed in a cuvette, and the baseline UV/visible spectrum was recorded at room temperature. For ODQ effect, pure oxyMb (6 M) was mixed with ODQ (30 M), and the spectra were recorded. Hb preparation. Hb was prepared in a manner similar to that reported above for Mb.
Expression and purification of recombinant Cygb. The expression plasmids (human CYGB cDNA in pET3a) were obtained from Dr. Thorsten Burmester (Mainz, Germany) and transformed into Escherichia coli and Cygb expressed and purified as reported (10) . Cygb fractions were concentrated by Amicon filtration (PM10) and passed though a Sephacryl S 200 column and then pooled and stored at Ϫ80°C. PBS containing Cygb (5 M) was placed in a cuvette and the baseline UV/visible spectrum recorded at room temperature. For ODQ effect, Cygb (5 M) was mixed with ODQ (30 M), and the spectra were recorded.
Chemicals and Reagents
Ammonium iron(II) sulfate hexahydrate, BSA, DMSO, DETC, sodium nitrite (nitrite), ODQ, human HbA (ferrous stabilized), skeletal Mb (equine), L-NAME, rotenone, oxypurinol, and myxothiazol were purchased from Sigma. 17-ODYA was purchased from Biomol (Plymouth Meeting, PA).
15 N-sodium nitrite was purchased from Cambridge Isotope Laboratories (Andover, MA), and PBS without calcium or magnesium was obtained from GIBCO/Invitrogen (Carlsbad, CA). All other chemicals were of the highest grade available.
Data Analysis
All results are expressed as the means Ϯ SE. Data were analyzed either by two-tailed Student's t-test for paired data from the same experiment and unpaired data from different experiments. Values of P Ͻ 0.05 were considered to be statistically significant.
RESULTS

Concentration-dependent effects of nitrite on in vivo hemodynamics of anesthetized rats.
Nitrite, administered noncumulatively, significantly reduced BP and heart rate in anesthetized rats (Fig. 1, A, B , and C) at normal body temperature (37°C). Baseline systolic BP, diastolic BP, and heart rate in anesthetized rats were 134 Ϯ 6 mmHg, 116 Ϯ 6 mmHg, and 322 Ϯ 8 bpm, respectively, n ϭ 4. Nitrite at 1 M had no clear effect on the BP, but, at 10 M and higher concentrations, it significantly decreased BP in a concentration-dependent manner (Fig. 1) . Systolic BPs at 10 M, 100 M, 500 M, 1 mM, and 2 mM nitrite were 128 Ϯ 6, 102 Ϯ 4, 83 Ϯ 6, 65 Ϯ 5, and 53 Ϯ 6 mmHg, respectively, and diastolic BPs were 111 Ϯ 7, 86 Ϯ 7, 59 Ϯ 6, 49 Ϯ 8, and 39 Ϯ 4 mmHg, respectively. Corresponding heart rates were 308 Ϯ 10, 290 Ϯ 12, 272 Ϯ 16, 248 Ϯ 13, and 227 Ϯ 19 beats/min, respectively. The percentage decrease in both systolic and diastolic BP by nitrite, calculated as the percentage decrease with respect to the maximal BP decrease from the baseline by 2 mM nitrite, was comparable for each concentration (Fig. 1, A and B) .
Concentration-dependent effects of nitrite on isolated rat aorta. Nitrite applied cumulatively relaxed aortic rings precontracted with phenylephrine in aerobic conditions at pH 7.4, 37°C ( Fig. 2A) . In the neutral buffer environment, the threshold concentration of nitrite to induce vasorelaxation was 10 M, and the aortic segment relaxed almost to basal tone at 2 mM concentration (Fig. 2B) . We also observed that the precontracted endothelium-denuded aortic rings relaxed in an identical manner (data not shown) as seen for the endothelium-intact aortic rings. The extent of relaxation caused by 10 M, 100 M, 1 mM, and 2 mM nitrite was 5 Ϯ 2, 38 Ϯ 3, 88 Ϯ 5, and 97 Ϯ 3% of phenylephrine contraction, respectively, n ϭ 5 (Fig. 2B) .
Role of NO and effect of oxyhemoglobin on nitrite-induced vasorelaxation. Oxyhemoglobin (oxyHb) is a highly effective NO scavenger, and its vasoconstrictant effect was examined under aerobic conditions at pH 7.4 (37°C). When phenylephrine-contracted aortic rings were prerelaxed with nitrite (100 M) application of 20 M oxyHb immediately abolished the nitrite-induced relaxation (Fig. 3A) . Of note, although oxyHb rapidly scavenges NO, it also much more slowly oxidizes nitrite over a period of minutes. Since the constriction effect of oxyHb was almost instant this suggests that it is due to NO scavenging rather than nitrite consumption. To further confirm this, experiments were also performed with higher nitrite concentrations so that oxyHb could not possibly scavenge the added nitrite. With 500 M nitrite, 20 M oxyHb rapidly reversed the observed relaxation, but as expected, after 10 -20 min, this effect was reversed as the oxyHb was oxidized (Fig. 3B) .
Role of sGC and effect of ODQ on nitrite-induced vasorelaxation. The influence of ODQ, a sGC inhibitor, on nitriteinduced vasorelaxation was examined in two series of experiments under aerobic conditions at pH 7.4 (37°C) as described in MATERIALS AND METHODS. In the first series, ODQ (10 M) was seen to produce marked augmentation of phenylephrineinduced contraction, and with subsequent addition of nitrite there was no vasorelaxant effect (Fig. 4A) . In the second series, following phenylephrine-induced contraction, nitrite was added, and relaxation was seen. However, ODQ not only reversed the nitrite-induced relaxation but also it further augmented the contraction above the tension seen with phenylephrine alone (Fig. 4B) . Also, with subsequent addition of authentic NO (3 M), from NO gas, no relaxation was seen.
Effects of different inhibitors on nitrite-induced vasorelaxation. Involvement of several potential mechanisms for nitritemediated vasorelaxation was examined under aerobic conditions at pH 7.4 (37°C) using selective inhibitors/agents. The DMSO and methanol vehicles had only minor relaxant effects on the phenylephrine-contracted aortic rings, 5.4 Ϯ 0.5 and 3.9 Ϯ 0.6%, respectively, n ϭ 4, and nitrite-induced (500 M) aortic relaxation was not affected by DMSO or methanol. Importantly, oxypurinol (50 M), rotenone (10 M), myxothiazol (10 M), 17-ODYA (50 M), and L-NAME (100 M) did not inhibit or decrease the nitrite-induced vasorelaxation (Fig. 5) . This indicates that this aortic relaxation under aerobic conditions is not due to XOR, mitochondrial electron transport chain, cytochrome P450, or NOS.
Electrochemical measurements of nitrite-induced NO. To detect nitrite-induced NO generation from isolated aortic segments under aerobic conditions (pH 7.4, 37C), a modified organ bath and an electrochemical analyzer were used. First, nitrite-induced NO was determined in the aortic preparations, and the influence of oxyHb was then examined. Nitrite (500 M) induced a marked increase in NO concentration (ϳ90 nM) from both endothelium-intact (Fig. 6A ) and endotheliumdenuded (Fig. 6B) aortic preparations, and administration of oxyHb (50 M) totally but transiently abolished this NO. To examine whether sGC or similar heme proteins blocked by ODQ are involved in nitrite-induced NO generation under aerobic conditions (pH 7.4, 37°C), the effect of ODQ (10 M) was determined. ODQ completely inhibited the nitrite-induced NO generation (Fig. 6C) .
EPR measurements of nitrite-induced NO. To further measure nitrite-induced NO from aortic tissue under aerobic conditions, EPR spin-trapping measurements were performed (Fig. 7) .
The typical triplet spectrum of NO-Fe 2ϩ -DETC was seen when NO (15 M) was added to aortic tissue (Fig. 7A) . A similar triplet EPR spectrum of 14 NO-Fe 2ϩ -DETC was produced by addition of natural abundance 14 N nitrite (500 M) to aortic tissue (Fig. 7B) . When aortic tissue was exposed to 15 N nitrite (500 M), the prominent doublet signal of 15 NO-Fe 2ϩ -DETC was detected definitively demonstrating that the NO was nitrite derived (Fig. 7C) .
To examine whether the nitrite-mediated NO generation occurs through an enzymatic process and whether sGC or similar heme proteins were involved, the effects of high temperature (100°C, 8 min) and ODQ (20 M) were determined. Figure 7D shows that the 14 NO-Fe 2ϩ -DETC signal from aortic tissue was completely abolished by preheating. Importantly, pretreatment of the aortic tissue with ODQ abolished the 14 NO-Fe 2ϩ -DETC signal (Fig. 7E) . No 14 NO-Fe 2ϩ -DETC signal was seen in the absence of aortic tissue (Fig. 7F) .
We also examined the effects of CO on nitrite-mediated NO generation. Figure 8C shows the typical triplet of NO-Fe 2ϩ -DETC complex seen when NO (5 M) was added to aortic tissue preexposed to CO, and Fig. 8B shows the EPR spectra of 14 NO-Fe 2ϩ -DETC produced by 14 N nitrite from aortic tissue. Pretreatment of aorta with CO abolished this nitrite-derived 14 NO-Fe 2ϩ -DETC signal (Fig. 8A) . Thus CO blocks nitritemediated NO generation from aorta.
Specificity of ODQ: possible involvement of other heme proteins.
To test whether ODQ is specific for the heme of sGC, UV visible spectra for oxyMb and Cygb were detected in room air-equilibrated buffer in the absence and presence of ODQ. Figure 9A shows the visible spectrum of pure oxyMb (6 M) with two distinct peaks at 543 and 581 nm wavelength. After the addition of ODQ (30 M), these peaks were quenched. Figure 9B shows the similar visible spectrum of pure reduced Cygb (5 M) with two distinct peaks at 531 and 560 nm wavelength. In the presence of ODQ (30 M), these peaks were also quenched. Thus ODQ not only inhibits sGC but also interacts with other heme proteins such as Mb and Cygb.
DISCUSSION
The results of the present study demonstrate that, under aerobic conditions, exogenous nitrite caused a dose-dependent decrease in the BP of anesthetized rats in parallel with a concentration-dependent vasorelaxation of rat aorta in vitro.
Associated key findings are that 1) nitrite produced NO from isolated rat aorta under aerobic conditions; 2) both vasorelaxation and NO generation were inhibited by oxyHb; 3) both vasorelaxation and NO generation were abolished by a sGC inhibitor ODQ; and 4) EPR spectra of nitrite-derived NO from aorta were abolished by heat, ODQ, and CO. Thus our in vivo and in vitro functional data in concert with electrochemical and spectroscopic findings demonstrate that the dose-dependent vasodilatory effects of exogenous inorganic nitrite are due to NO formation with this process mediated by sGC and/or other heme enzymes under aerobic conditions.
Vasodilatory action of nitrite under aerobic conditions. Despite initial controversy (30), recent studies have repeatedly shown that under normoxic conditions, exogenous nitrite can cause potent vasodilation in both animals and humans (5, 6, 35, 36) . In vivo BP lowering and in vitro vasorelaxing effects of nitrite in the present study were within the same concentration range (Figs. 1 and 2) , and the magnitude of nitrite-induced changes were comparable both in vivo and in vitro, thus reaffirming that the vasodilating effects of nitrite are present in aerobic conditions. We observed that the threshold concentration of nitrite was at ϳ10 M for both BP and vasorelaxant effects, which is within the range of normal physiological tissue levels. Our findings are also consistent with published reports where similar concentrations of nitrite decreased BP (3, 60) and/or elicited aortic vasorelaxation in aerobic conditions (6, 37, 57) . In a recent study now ongoing in our laboratory, we have performed in vivo thermodilution measurements of the dose-dependent effect of nitrite on cardiac output (Cardiomax-III; Columbus Instruments, Columbus, OH) and observed that Fig. 8 . Representative EPR spectra for NO-Fe 2ϩ -DETC complex formed from isolated rat aorta with added nitrite or NO at 77 K. EPR spin-trapping measurements were performed using a Bruker EMX spectrometer operating at X-band, 9.53 GHz, and aorta were prepared as described in Fig. 7 . Treatment of aorta with CO totally abolished 14 NO-Fe 2ϩ -DETC signal for nitrite (A). B: EPR spectra for 14 NO-Fe 2ϩ -DETC complex produced by 14 N nitrite (1 mM) from aortic tissue; C: typical triplet of NO-Fe 2ϩ -DETC complex from NO (5 M) with aortic tissue treated with CO. Each spectrum is representative of at least 5 independent experiments. Please note that the C is presented at 1:10 magnitude of all others. Fig. 7 . Representative electron paramagnetic resonance (EPR) spectra for NO-Fe 2ϩ -DETC complex formed from isolated rat aorta in the presence of added nitrite or NO at 77 K. EPR measurements were performed using a Bruker ER 300 spectrometer operating at X-band, 9.77 GHz. Aorta were incubated in PBS with 0.5% BSA, nitrite (500 M), ammonium-iron(II) sulfate (1 mM the nitrite-induced decreases in systolic, diastolic, and mean arterial pressure (MAP) occur without alterations in cardiac output. Since MAP depends on both cardiac output and systemic vascular resistance (SVR), the decreases in blood pressure seen in our experiments are due to vasodilation with decrease in SVR.
Typical nitrite levels in plasma are in the range of 0.3 to 1.0 M, and the concentration in aortic tissue is 10 -20 M (5, 49). Since the threshold concentration of nitrite to elicit vasorelaxant effects was also 10 M, this suggests that basal nitrite levels have only slight effects on vascular tone but that increases associated with pharmacological administration or disease can elicit prominent vasodilatation.
Nitrite-induced vasorelaxation: role of NO and sGC. With its well-recognized NO-scavenging effect (25, 51) , the inhibition of relaxation by oxyHb serves as a classical measure of the role of NO in vasorelaxation. In the present study, we observed that nitrite caused dose-dependent vasodilation, and this was inhibited by oxyHb demonstrating a critical role of NO in this process. Furthermore, this relaxation was totally blocked by the sGC blocker ODQ indicating a key role of NO-mediated activation of sGC. Although Hb has also been proposed to play key roles as a nitrite reductase in hypoxia and as a donor of NO at the site of hypoxia through S-nitrosohemoglobin (24, 27, 51, 55) , from our studies under aerobic conditions, it is clear that Hb does not facilitate nitrite-mediated vascular relaxation but blocks this process.
Nitrite-mediated NO formation was directly measured in aerobic aorta by both electrochemical (Fig. 6 ) and EPR spin-trapping techniques (Figs. 7 and 8) . Importantly, both nitrite-induced vasodilation (Fig. 3) and nitrite-induced NO generation (Fig. 6A) were acutely inhibited by oxyHb. Thus a nitrite-NO-vasodilation pathway exists in aerobic vessels, and cell-free Hb is a potent scavenger, not a source of this nitrite-induced NO. Dalsgaard et al. (6) reported that oxyHb inhibits nitrite-induced vasodilation, whereas deoxyHb preserves it. Recently, Isbell et al. (22) also demonstrated that nitrite-dependent vasodilation is inhibited at high oxygen fractional saturation, whereas vasodilation is promoted when Hb deoxygenates. These results are consistent with deoxyHb both scavenging and generating NO but only scavenging by oxyHb.
Since NO is paramagnetic and reacts to form high-affinity complexes with a variety of metal chelates and metalloproteins (20) , the distinctive EPR spectra of these NO complexes can provide real-time measurements of NO generation. Our EPR studies of aortic vessels demonstrated prominent nitrite-derived NO generation with the typical triplet EPR spectra of natural abundance 14 NO (Fig. 7B) . Isotope tracer studies with 15 N nitrite demonstrated that the NO was nitrite derived since the characteristic doublet 15 NO signal was observed. Nitriteinduced NO was absent when the aortic tissue was preheated (Fig. 7D) , suggesting that it is derived from an enzymatic process. This is consistent with a previous report where both NOS-derived and nitrite-derived NO generation showed a similar thermal sensitivity (1) .
Mechanisms of nitrite-induced NO formation. Recently, several potential mechanisms have been proposed for nitritemediated vasodilation during hypoxia (6, 8, 27, 28) . Enzymatic pathways including xanthine oxidase, mitochondrial electron transport complexes, cytochrome P450 reductase, and endothelial NOS have been shown to reduce nitrite to NO (17, 27, 31-33, 35, 40, 48, 50, 58, 64, 65) . In general, these pathways are greatly increased under anaerobic or hypoxic conditions, and questions have remained regarding their role in the nitritemediated NO generation in aerobic vessels. However, in the present study, we observed that under aerobic conditions, selective inhibitors of each of the above pathways such as oxypurinol, rotenone, myxothiazol, 17-ODYA, and L-NAME did not block nitrite-induced aortic vasorelaxation. Dejam et al. (8) reported that allopurinol did not inhibit but enhanced nitrite-induced vasodilation in humans. Dalsgaard et al. (6) also demonstrated no effects of allopurinol and myxothiazol on nitrite-induced aortic vasorelaxation during hypoxia. Recently, we have reported that xanthine oxidase and aldehyde oxidase do play a critical role in nitrite-induced NO generation in the heart and liver under anaerobic conditions (34) . However, we showed that NO generation from nitrite in these tissues was dependent on reducing substrate concentrations and inhibited by increasing oxygen tension. From these prior studies and our present results, it is clear that the mechanisms of nitrite reduction in anaerobic tissues are quite different from that in normoxic vessels. Thus our present findings indicate that a novel pathway is involved in nitrite-induced aortic vasorelaxation and NO production in aerobic vessels.
CO binds with high affinity to the ferrous iron of heme proteins and blocks the heme and any heme-mediated electron transfer (26) . In the presence of CO, there was no detectable EPR spectrum for nitrite-induced NO from the aortic tissue (Fig. 8A) . These results thus indicate that heme proteins in aortic tissue are involved in nitrite-induced NO formation.
The heme-containing sGC is a major intracellular effector enzyme of NO (9) and mediates many biological actions such as vascular smooth muscle relaxation by increasing cGMP. Binding of NO or NO donors to the ferrous heme iron of sGC induces a change in heme geometry and activates the enzyme catalyzing the formation of cGMP from GTP (9) . ODQ has been shown to be a potent inhibitor of sGC without production of superoxide (16) . The mechanism of action of ODQ is believed to be specifically related to oxidation of the heme moiety (53) , and this greatly decreases the sensitivity of the prosthetic heme group of sGC for NO and thus prevents cGMP formation.
In the present study, ODQ produced marked contraction in isolated aortic rings precontracted with phenylephrine (Fig. 4) , indicating the involvement of constitutively active sGC in arterial smooth muscle. It is important to note that nitriteinduced vasorelaxation was absent when ODQ was applied either before (Fig. 4A) or after (Fig. 4B) nitrite, suggesting the possibility of a direct interaction between sGC and nitrite in addition to the classical NO-cGMP pathway. Since ODQ totally abolished nitrite-mediated vasodilation, we questioned whether it would also block nitrite-mediated NO generation. Interestingly, ODQ completely blocked this NO formation and abolished the EPR spectra of nitrite-derived NO (Fig. 7E) . We further noted that nitrite-induced vasorelaxation and NO formation was endothelium independent (Fig. 6B) . Therefore, blockade of nitrite-induced vasorelaxation and NO generation with ODQ treatment suggests that nitrite and/or its secondary NO may be directly interacting with aortic smooth muscle sGC.
Nitrite-induced-NO pathway: are other heme proteins involved? Although ODQ has been widely utilized and considered as a specific sGC inhibitor, it has also been reported that ODQ can interfere with other heme proteins (12) . ODQ has been spectroscopically shown to interact with and oxidize the ferrous heme of sGC (52) ; however, it may also target the heme group of other proteins such as Hb (39) .
It has been recently hypothesized that the heme globin family (hemoglobin, myoglobin, cytoglobin, and neuroglobin) can function as nitrite reductases (27, 35, 43, 48) . Mb is an important intracellular oxygen-binding protein and a potent NO scavenger (62) . Although Mb has been reported to be present in human aorta, it has not been detected (46) and is believed not to be present in rat aorta (23) . Interestingly, in rat cardiac homogenates, deoxyMb has been shown to be a nitrite reductase that generates NO and regulates mitochondrial respiration (54) . Moreover, a nitrite reductase function of deoxyMb has been reported in hypoxic wild-type but not in Mb knockout heart (47) . Recently, a small novel heme protein, Cygb, with similar characteristics to Mb has been identified in a broad range of tissues (18) . We observed that the optical spectra of ferrous Mb (Fig. 9A) and Cygb (Fig. 9B) were altered by ODQ with apparent oxidation of the heme to the ferric state as also occurs for sGC (42) , demonstrating that ODQ not only targets the heme of sGC but also that of Mb, Cygb, and perhaps other similar heme proteins (43) .
In conclusion, under aerobic conditions, nitrite evokes a dose-dependent vasorelaxation of precontracted rat aorta and also causes a dose-dependent decrease in blood pressure in anesthetized rats. Both functional and analytical studies demonstrate that the vasorelaxant effect of nitrite is mediated by NO formation mediated through sGC or other heme proteins inhibitable by ODQ. Taken together, our findings provide strong evidence that a ferrous heme protein in aortic smooth muscle is involved in nitrite-induced NO production under normal aerobic conditions. Future research with the use of improved molecular probes and antibodies will be required to address the precise role of sGC, Cygb, or the other heme proteins in the process of nitrite-mediated NO production and vasodilation in normoxic vessels.
